carmustine has been researched along with bromodeoxyuridine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Hahn, GM | 1 |
| Fornace, AJ; Kann, HE; Kohn, KW | 1 |
| Berens, ME; Jung, HW; Krouwer, HG; Rosenblum, ML | 1 |
| Barcellos-Hoff, MH; Deen, DF; Marton, LJ | 1 |
| Gutin, PH; Nelson, DF; Saunders, WM; Sheline, GE; Urtasun, RC | 1 |
| Biegel, JA; Boggs, SS; Conner, MK | 1 |
| Diksic, M; Takeda, N; Yamamoto, YL | 1 |
| Glaze, ER; Greenberg, HS; Mancini, WR; Stetson, PL | 1 |
| Bates, SE; Holbeck, SL; Kohlhagen, G; Medina-Perez, W; Mertins, SD; Myers, TG; Pommier, Y; Wang, E | 1 |
| Ateş, U; Baka, M; Elmas, C; Sezer, E; Sözmen, EY; Turgut, M; Ulker, S; Uyanikgil, Y; Yavaşoğlu, A; Yurtseven, ME | 1 |
1 review(s) available for carmustine and bromodeoxyuridine
| Article | Year |
|---|---|
Recent and current investigations of radiation therapy of malignant gliomas.
Topics: Brachytherapy; Brain; Brain Neoplasms; Bromodeoxyuridine; Carmustine; Glioma; Helium; Humans; Hyperbaric Oxygenation; Hyperthermia, Induced; Mesons; Metronidazole; Middle Aged; Misonidazole; Neon; Neutrons; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy, High-Energy | 1986 |
11 other study(ies) available for carmustine and bromodeoxyuridine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Repair (or recovery) effects in quiescent Chinese hamster cells: an attempt at classification.
Topics: Bleomycin; Bromodeoxyuridine; Carmustine; Cell Line; DNA Repair; Hot Temperature; Mesylates; Methyl Methanesulfonate; Radiation Effects; Ultraviolet Rays | 1975 |
Inhibition of the ligase step of excision repair by 2-chloroethyl isocyanate, a decomposition product of 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Bromodeoxyuridine; Carmustine; Cell Line; Cyanates; DNA Ligases; DNA Repair; DNA, Single-Stranded; Ethyl Chloride; Isocyanates; Polynucleotide Ligases; Ultraviolet Rays | 1978 |
A three-dimensional micro-organ culture system optimized for in vitro growth of human malignant brain tumors.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carmustine; Cell Survival; Glioma; Humans; Immunohistochemistry; Macrophages; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1991 |
Differential drug sensitivity conferred by growth status detected in a mixed population of cycling and noncycling cells.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carmustine; Cell Cycle; DNA Damage; DNA, Neoplasm; Rats; Sister Chromatid Exchange; Time Factors; Tumor Cells, Cultured | 1990 |
Cellular replication kinetics and persistence of sister chromatid exchange-inducing lesions in normal and lymphoma AKR cells following exposure to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Animals; Bone Marrow; Bromodeoxyuridine; Carmustine; Cell Cycle; Cell Division; Cell Line; Crossing Over, Genetic; Lymphoma; Mice; Mice, Inbred AKR; Neoplasm Transplantation; Sister Chromatid Exchange | 1982 |
The sequential changes in DNA synthesis, glucose utilization, protein synthesis, and peripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Bromodeoxyuridine; Carmustine; DNA; Female; Glioma; Glucose; Immunohistochemistry; Monitoring, Physiologic; Protein Biosynthesis; Rats; Rats, Wistar; Receptors, GABA-A | 1996 |
Sensitization of 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin cytotoxicity by 5-bromo-2'-deoxyuridine in human glioma.
Topics: Bromodeoxyuridine; Carmustine; Cell Survival; DNA Damage; DNA, Neoplasm; Drug Synergism; Glioma; Humans; Kinetics; Tumor Cells, Cultured | 1999 |
In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity.
Topics: Alkylating Agents; Animals; Bromodeoxyuridine; Busulfan; Carcinoma, Renal Cell; Carmustine; Cell Cycle; DNA Damage; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Mesylates; Rats; Tumor Suppressor Protein p53; Yeasts | 2004 |
Neuroprotective effects of melatonin upon the offspring cerebellar cortex in the rat model of BCNU-induced cortical dysplasia.
Topics: Animals; Animals, Newborn; Brain Diseases; Bromodeoxyuridine; Carmustine; Cerebellar Cortex; Disease Models, Animal; Female; In Situ Nick-End Labeling; Malondialdehyde; Melatonin; Microscopy, Electron, Transmission; Nerve Tissue Proteins; Neuroprotective Agents; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Superoxide Dismutase; Transforming Growth Factor beta1 | 2007 |